Option Care Health (NASDAQ:OPCH) Hits New 1-Year Low – Here’s Why

Option Care Health, Inc. (NASDAQ:OPCH)’s stock price reached a new 52-week low during trading on Wednesday . The stock traded as low as $22.20 and last traded at $22.28, with a volume of 747109 shares. The stock had previously closed at $22.85.

Analysts Set New Price Targets

Several research firms have recently commented on OPCH. Barrington Research reduced their price objective on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. The Goldman Sachs Group downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $38.00 to $27.00 in a report on Monday, November 4th. Truist Financial dropped their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday, November 1st. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Finally, JMP Securities upped their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a report on Monday, September 30th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Option Care Health has an average rating of “Moderate Buy” and an average target price of $30.83.

Option Care Health Trading Down 2.9 %

The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock’s 50 day moving average price is $29.24 and its 200-day moving average price is $29.54. The stock has a market capitalization of $3.77 billion, a P/E ratio of 18.80, a P/E/G ratio of 2.37 and a beta of 1.32.

Insider Activity

In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares in the company, valued at $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

A number of institutional investors have recently modified their holdings of the company. Blue Trust Inc. lifted its position in shares of Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after purchasing an additional 377 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after acquiring an additional 471 shares during the last quarter. Lindenwold Advisors INC grew its position in shares of Option Care Health by 5.4% during the third quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock worth $299,000 after acquiring an additional 489 shares during the last quarter. Trust Point Inc. grew its position in Option Care Health by 2.6% in the 3rd quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock valued at $755,000 after buying an additional 622 shares in the last quarter. Finally, Nisa Investment Advisors LLC grew its position in Option Care Health by 5.4% in the 2nd quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock valued at $376,000 after buying an additional 690 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.